Literature DB >> 17460196

A dual role of p21 in stem cell aging.

Zhenyu Ju1, Aaheli Roy Choudhury, K Lenhard Rudolph.   

Abstract

A decline in adult stem cell function occurs during aging, likely contributing to the decline in organ homeostasis and regeneration with age. An emerging field in aging research is to analyze molecular pathways limiting adult stem cell function in response to macromolecular damage accumulation during aging. Current data suggest that the p21 cell cycle inhibitor has a dual role in stem cell aging: On one hand, p21 protects adult stem cells from acute genotoxic stress by preventing inappropriate cycling of acutely damaged stem cells. On the other hand, p21 activation impairs stem cell function and survival of aging telomere dysfunctional mice indicating that p21 checkpoint function is disadvantageous in the context of chronic and persistent damage, which accumulates during aging. This article focuses on these dual roles of p21 in aging stem cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17460196     DOI: 10.1196/annals.1395.036

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  30 in total

1.  Hypoxic preconditioning induces the expression of prosurvival and proangiogenic markers in mesenchymal stem cells.

Authors:  Simi M Chacko; Shabnam Ahmed; Karuppaiyah Selvendiran; M Lakshmi Kuppusamy; Mahmood Khan; Periannan Kuppusamy
Journal:  Am J Physiol Cell Physiol       Date:  2010-09-22       Impact factor: 4.249

2.  The multifunctional sorting protein PACS-2 regulates SIRT1-mediated deacetylation of p53 to modulate p21-dependent cell-cycle arrest.

Authors:  Katelyn M Atkins; Laura L Thomas; Jonathan Barroso-González; Laurel Thomas; Sylvain Auclair; Jun Yin; Hyeog Kang; Jay H Chung; Jimmy D Dikeakos; Gary Thomas
Journal:  Cell Rep       Date:  2014-08-21       Impact factor: 9.423

3.  Osteopontin stimulates preneoplastic cellular proliferation through activation of the MAPK pathway.

Authors:  Xianmin Luo; Megan K Ruhland; Ermira Pazolli; Anne C Lind; Sheila A Stewart
Journal:  Mol Cancer Res       Date:  2011-06-14       Impact factor: 5.852

4.  Telomere dysfunction and cell cycle checkpoints in hematopoietic stem cell aging.

Authors:  Zhenyu Ju; Junling Zhang; Yingdai Gao; Tao Cheng
Journal:  Int J Hematol       Date:  2011-06-14       Impact factor: 2.490

5.  Placental aging and oxidation damage in a tissue micro-array model: an immunohistochemistry study.

Authors:  Ambrogio P Londero; Maria Orsaria; Stefania Marzinotto; Tiziana Grassi; Arrigo Fruscalzo; Angelo Calcagno; Serena Bertozzi; Nastassia Nardini; Enrica Stella; Ralph J Lellé; Lorenza Driul; Gianluca Tell; Laura Mariuzzi
Journal:  Histochem Cell Biol       Date:  2016-04-22       Impact factor: 4.304

6.  Oxidative Stress Increases the Number of Stress Granules in Senescent Cells and Triggers a Rapid Decrease in p21waf1/cip1 Translation.

Authors:  Xian Jin Lian; Imed-Eddine Gallouzi
Journal:  J Biol Chem       Date:  2009-01-28       Impact factor: 5.157

7.  Antioxidation of decellularized stem cell matrix promotes human synovium-derived stem cell-based chondrogenesis.

Authors:  Ming Pei; Ying Zhang; Jingting Li; Dongquan Chen
Journal:  Stem Cells Dev       Date:  2012-12-16       Impact factor: 3.272

Review 8.  Cdc42 and aging of hematopoietic stem cells.

Authors:  Hartmut Geiger; Yi Zheng
Journal:  Curr Opin Hematol       Date:  2013-07       Impact factor: 3.284

9.  Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy.

Authors:  P Cipriani; P Di Benedetto; V Liakouli; B Del Papa; M Di Padova; M Di Ianni; A Marrelli; E Alesse; R Giacomelli
Journal:  Clin Exp Immunol       Date:  2013-08       Impact factor: 4.330

Review 10.  Sirtuin 1, stem cells, aging, and stem cell aging.

Authors:  Charlie Mantel; Hal E Broxmeyer
Journal:  Curr Opin Hematol       Date:  2008-07       Impact factor: 3.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.